Similarly, the use of small molecule inhibitors or antisense RNA strategies to inhibit CSF-1R signaling, also inhibited tumor growth in both xenograft and genetically engineered mouse models [45,46,47]. This evidence concerns the gene CSF1R and neoplasm.